InvestSMART

Oncosil Medical Limited (ASX: OSL) - Announcements

- Current share price for OSL : $0.940

ASX company news and announcements for Oncosil Medical Limited (OSL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Oncosil Medical Limited (OSL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Oncosil Medical Limited (OSL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Oncosil Medical Limited (OSL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$35 Final Director's Interest Notice 19 Oct 2021 6:11PM $0.047 $0.940 risen by 1,900%
$35 Results of the OncoSil 2021 Annual General Meeting 19 Oct 2021 6:07PM $0.047 $0.940 risen by 1,900%
$35 2021 AGM CEO Presentation 19 Oct 2021 9:34AM $0.044 $0.940 risen by 2,036.36%
$35 2021 AGM Chairman's Address 19 Oct 2021 9:31AM $0.044 $0.940 risen by 2,036.36%
$35 Resignation of Director - Dr Roger Aston 19 Oct 2021 9:27AM $0.044 $0.940 risen by 2,036.36%
$35 Prof. Ricky Sharma appointed to the Board of OncoSil 12 Oct 2021 10:43AM $0.046 $0.940 risen by 1,943.48%
$35 Receipt of $1.077m R&D Tax Incentive Refund 27 Sep 2021 8:53AM $0.046 $0.940 risen by 1,943.48%
$35 Notice of General Meeting/Proxy Form 17 Sep 2021 4:06PM $0.048 $0.940 risen by 1,858.33%
$35 Change of Director's Interest Notice 25 Aug 2021 9:54AM $0.049 $0.940 risen by 1,818.37%
$35 Appendix 4G and Corporate Governance Statement 19 Aug 2021 9:30AM $0.051 $0.940 risen by 1,743.14%
$35 Appendix 4E Announcement 19 Aug 2021 9:29AM $0.051 $0.940 risen by 1,743.14%
$35 Appendix 4E and Annual Report 19 Aug 2021 9:29AM $0.051 $0.940 risen by 1,743.14%
$35 Cancellation of shares under the Employee Share Plan 11 Aug 2021 4:13PM $0.053 $0.940 risen by 1,673.58%
$35 Quarterly Activities/Appendix 4C Cash Flow Report 26 Jul 2021 8:56AM $0.060 $0.940 risen by 1,466.67%
$35 Initial Director's Interest Notice 21 Jul 2021 9:47AM $0.059 $0.940 risen by 1,493.22%
$35 Otto Buttula appointed to the Board of OncoSil 20 Jul 2021 9:42AM $0.061 $0.940 risen by 1,440.98%
$35 OncoSil TGA regulatory update 2 Jun 2021 3:50PM $0.076 $0.940 risen by 1,136.84%
$35 Cancellation of loan funded shares 10 May 2021 4:06PM $0.090 $0.940 risen by 944.44%
$35 Change of Director's Interest Notice 10 May 2021 4:06PM $0.090 $0.940 risen by 944.44%
$35 OncoSil receives regulatory approval from Hong Kong 4 May 2021 3:19PM $0.093 $0.940 risen by 910.75%
$35 Appendix 4C - quarterly 29 Apr 2021 5:09PM $0.099 $0.940 risen by 849.49%
$35 Change of Registered Office and Principal Place of Business 1 Mar 2021 9:09AM $0.100 $0.940 risen by 840%
$35 Business update call transcript 26 Feb 2021 8:12AM $0.110 $0.940 risen by 754.55%
$35 Half Yearly Report and Accounts 23 Feb 2021 12:15PM $0.110 $0.940 risen by 754.55%
$35 Half-Yearly Report Results 23 Feb 2021 12:15PM $0.110 $0.940 risen by 754.55%

451 - 475 of 810 results

Page 19 of 33

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.